Product Details
Application
- Immunization
- Cell based assay (FACS or functional assay)
- Screening (ELISA)
Synonyms
NY-ESO-1 TCR & CD3E & CD3D & CD3G & CD3Z
Source
Human NY-ESO-1 TCR & CD3 Full Length Protein Complex (VLP) (NYZ-H5213) is expressed from human 293 cells (HEK293). It contains AA Asp 23 - Ile 207 & Phe 22 - Lys 171 & Gln 23 - Asn 182 & Gln 22 - Arg 164 (Accession # P07766-1 & P04234-1 & P09693-1 & P20963-1).
Predicted N-terminus: Met
Molecular Characterization
*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.
Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.
Synthesis Process
Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Formulation
The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).
Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping and Storage
This product is supplied and shipped on dry ice.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA

Immobilized Human NY-ESO-1 TCR & CD3 Full Length Protein Complex (VLP) (Cat. No. NYZ-H5213) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3), premium grade (Cat. No. CDE-M120a) with a linear range of 2-31 ng/mL (QC tested).
Protocol
Immobilized Human NY-ESO-1 TCR & CD3 Full Length Protein Complex (VLP) (Cat. No. NYZ-H5213) at 1 μg/mL (100 μL/well) can bind Anti-KLK2×CD3 Antibody (Pasritamig Biosimilar) with a linear range of 0.2-250 ng/mL (Routinely tested).
Protocol
Customer Reviews Writing Reviews




















